1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. FGFR
  4. FGFR Inhibitors

FGFR Inhibitors

FGFR

FGFR1

FGFR2

FGFR3

FGFR4

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

FGFR Inhibitors
Product Name FGFR FGFR1 FGFR2 FGFR3 FGFR4 Purity
Lenvatinib  
FGFR1, IC50: 46 nM
      99.87%
Nintedanib  
FGFR1, IC50: 69 nM
FGFR2, IC50: 37 nM
FGFR3, IC50: 108 nM
  99.97%
Erdafitinib  
FGFR1, IC50: 1.2 nM
FGFR2, IC50: 2.5 nM
FGFR3, IC50: 3.0 nM
FGFR4, IC50: 5.7 nM
99.66%
Ponatinib  
FGFR1, IC50: 2.2 nM
      99.13%
Infigratinib  
FGFR1, IC50: 0.9 nM
FGFR2, IC50: 1.4 nM
FGFR3, IC50: 1 nM
FGFR4, IC50: 60 nM
99.55%
Dovitinib lactate hydrate  
FGFR1, IC50: 8 nM
 
FGFR3, IC50: 9 nM
 
E7090  
FGFR1, IC50: 0.71 nM
FGFR2, IC50: 0.50 nM
FGFR3, IC50: 1.2 nM
FGFR4, IC50: 120 nM
E7090 succinate  
FGFR1, IC50: 0.71 nM
FGFR2, IC50: 0.50 nM
FGFR3, IC50: 1.2 nM
FGFR4, IC50: 120 nM
Pemigatinib  
FGFR1, IC50: 0.4 nM
FGFR2, IC50: 0.5 nM
FGFR3, IC50: 1.2 nM
FGFR4, IC50: 30 nM
99.88%
AZD4547  
FGFR1, IC50: 0.2 nM
FGFR2, IC50: 2.5 nM
FGFR3, IC50: 1.8 nM
FGFR4, IC50: 165 nM
99.68%
Pazopanib  
FGFR1, IC50: 140 nM
      99.75%
SU 5402  
FGFR1, IC50: 30 nM
      99.39%
PD173074  
FGFR1, IC50: 25 nM
      99.67%
Futibatinib  
FGFR1, IC50: 3.9 nM
FGFR2, IC50: 1.3 nM
wild-type FGFR2, IC50: 0.3 nM
FGFR2 V5651, IC50: 1-3 nM
FGFR2 N550H, IC50: 3.6 nM
FGFR2 E566G, IC50: 2.4 nM
FGFR3, IC50: 1.6 nM
FGFR4, IC50: 8.3 nM
98.80%
Nintedanib esylate  
FGFR1, IC50: 69 nM
FGFR2, IC50: 37 nM
FGFR3, IC50: 108 nM
  99.93%
Fisogatinib        
FGFR4, IC50: 5 nM
99.87%
Dovitinib  
FGFR1, IC50: 8 nM
 
FGFR3, IC50: 9 nM
  99.94%
Roblitinib  
FGFR1, IC50: >10 μM
FGFR2, IC50: >10 μM
FGFR3, IC50: >10 μM
FGFR4, IC50: 1.9 nM
rat FGFR4, IC50: >10 μM
≥98.0%
Rogaratinib  
FGFR1
FGFR2
FGFR3
FGFR4
99.86%
BLU9931  
FGFR1, IC50: 591 nM
FGFR2, IC50: 493 nM
FGFR3, IC50: 150 nM
FGFR4, IC50: 3 nM
≥98.0%
LY2874455  
FGFR1, IC50: 2.8 nM
FGFR2, IC50: 2.6 nM
FGFR3, IC50: 6.4 nM
FGFR4, IC50: 6 nM
98.06%
KW-2449  
FGFR1, IC50: 36 nM
      99.85%
Gandotinib    
FGFR2, IC50: 32 nM
FGFR3, IC50: 106 nM
  99.82%
Ferulic acid  
FGFR1, IC50: 3.78 μM
FGFR2, IC50: 12.5 μM
    99.87%
Lucitanib  
FGFR1, IC50: 17.5 nM
FGFR2, IC50: 82.5 nM
    99.32%
Pazopanib Hydrochloride  
FGFR1, IC50: 140 nM
      99.84%
Alofanib    
FGFR2
    98.81%
PD-166866  
FGFR1, IC50: 52.4 nM
      99.97%
CH5183284  
FGFR1, IC50: 9.3 nM
FGFR2, IC50: 7.6 nM
FGFR3, IC50: 22 nM
FGFR4, IC50: 290 nM
99.73%
Sulfatinib  
FGFR1
      98.01%
Lenvatinib mesylate  
FGFR1, IC50: 46 nM
      99.86%
PRN1371  
FGFR1, IC50: 0.6 nM
FGFR2, IC50: 1.3 nM
FGFR3, IC50: 4.1 nM
FGFR4, IC50: 19.3 nM
99.72%
ENMD-2076  
FGFR1, IC50: 92.7 nM
FGFR2, IC50: 70.8 nM
    99.12%
CP-547632
FGFR, IC50: 9 nM
        ≥99.0%
Derazantinib  
FGFR1, IC50: 4.5 nM
FGFR2, IC50: 1.8 nM
FGFR3, IC50: 4.5 nM
  99.18%
PF 477736      
FGFR3, IC50: 23 nM
  99.21%
CP-547632 hydrochloride
FGFR, IC50: 9 nM
        98.24%
TG 100801  
FGFR1, IC50: 2 nM
FGFR2, IC50: 16 nM
    ≥95.0%
Orantinib  
FGFR1, Ki: 1.2 μM
      98.80%
ODM-203  
FGFR1, IC50: 11 nM
FGFR2, IC50: 16 nM
FGFR3, IC50: 6 nM
FGFR4, IC50: 35 nM
99.33%
Dovitinib lactate  
FGFR1, IC50: 8 nM
 
FGFR3, IC50: 9 nM
  99.96%
S49076  
FGFR1, IC50: 18 nM
FGFR1V561M, IC50: 23 nM
FGFR2, IC50: 17 nM
FGFR2N549H, IC50: 19 nM
FGFR3, IC50: 15 nM
  98.62%
ASP5878  
FGFR1, IC50: 0.47 nM
FGFR2, IC50: 0.6 nM
FGFR3, IC50: 0.74 nM
FGFR4, IC50: 3.5 nM
99.71%
FIIN-2  
FGFR1, IC50: 3.1 nM
FGFR2, IC50: 4.3 nM
FGFR3, IC50: 27 nM
FGFR4, IC50: 45 nM
99.95%
FIIN-3  
FGFR1, IC50: 13.1 nM
FGFR2, IC50: 21 nM
FGFR3, IC50: 31.4 nM
FGFR4, IC50: 35.3 nM
98.13%
R1530  
FGFR1, IC50: 28 nM
      99.06%
EOC317  
FGFR1, IC50: 6 nM
      98.11%
SSR128129E  
FGFR1, IC50: 1.9 μM
      99.86%
Tyrosine kinase-IN-1  
FGFR1, IC50: 2 nM
      99.47%
ENMD-2076 Tartrate  
FGFR1, IC50: 92.7 nM
FGFR2, IC50: 70.8 nM
    98.87%
Infigratinib phosphate  
FGFR1, IC50: 0.9 nM
FGFR2, IC50: 1.4 nM
FGFR3, IC50: 1 nM
FGFR4, IC50: 60 nM
97.74%
FGFR4-IN-1        
FGFR4, IC50: 0.7 nM
99.88%
PD-161570  
FGFR1, IC50: 39.9 nM
FGFR1, Ki: 42 nM
FGFR1 autophosphorylation, IC50: 622 nM
      99.04%
(Z)-Orantinib  
FGFR1, IC50: 1.2 μM
      99.02%
FGFR1/DDR2 inhibitor 1  
FGFR1, IC50: 31.1 nM
      99.03%
CP-547632 TFA
FGFR, IC50: 9 nM
        99.42%
TG 100572  
FGFR1, IC50: 2 nM
FGFR2, IC50: 16 nM
   
CPL304110  
FGFR1, IC50: 0.75 nM
FGFR2, IC50: 0.5 nM
FGFR3, IC50: 3.05 nM
 
FGFR4-IN-5    
FGFR2, IC50: 505 nM
 
FGFR4, IC50: 6.5 nM
98.06%
FGFR4-IN-4        
FGFR4
ARQ 069  
unphosphorylated FGFR1, IC50: 0.84 μM
FGFR1 autophosphorylation, IC50: 2.8 μM
unphosphorylated FGFR2, IC50: 1.23 μM
FGFR2 autophosphorylation, IC50: 1.9 μM
   
PD-089828  
FGFR1, IC50: 0.15 μM
FGFR1, Ki: 0.14 μM
     
FIIN-1  
FGFR1, Kd: 2.8 nM
FGFR1, IC50: 9.2 nM
FGFR2, Kd: 6.9 nM
FGFR2, IC50: 6.2 nM
FGFR3, Kd: 5.4 nM
FGFR3, IC50: 11.9 nM
FGFR4, Kd: 120 nM
FGFR4, IC50: 189 nM
SU4984  
FGFR1, IC50: 10-20 μM
     
Ponatinib D8  
FGFR1, IC50: 2.2 nM
     
TG 100801 Hydrochloride  
FGFR1, IC50: 2 nM
FGFR2, IC50: 16 nM
   
SSR128129E free acid  
FGFR1, IC50: 1.9 μM